Recap: VYNE Therapeutics Q1 Earnings

VYNE Therapeutics VYNE reported its Q1 earnings results on Thursday, May 11, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

VYNE Therapeutics beat estimated earnings by 43.3%, reporting an EPS of $-1.48 versus an estimate of $-2.61.

Revenue was down $79 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.27 which was followed by a 13.0% drop in the share price the next day.

Here's a look at VYNE Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -3.24 -3.06 -3.06 -2.88
EPS Actual -2.97 -2.52 -2.34 1.80
Revenue Estimate 60K 130K 100K 370K
Revenue Actual 6K 167K 126K 178K

To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!